AUDENTES THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by AUDENTES THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D2022-10-31Audentes Therapeutics, Inc.Taysha Gene Therapies, Inc.7,266,34211.6%EDGAR
SC 13G/A2020-02-14Partner Fund Management, L.P.Audentes Therapeutics, Inc.-2.7%EDGAR
SC 13G/A2020-02-14Redmile Group, LLCAudentes Therapeutics, Inc.639,0951.4%EDGAR
SC 13G/A2020-02-14GREAT POINT PARTNERS LLCAudentes Therapeutics, Inc.00.0%EDGAR
SC 13G2020-02-11VANGUARD GROUP INCAudentes Therapeutics, Inc.3,225,6137.0%EDGAR
SC 13G/A2020-02-05BlackRock Inc.Audentes Therapeutics, Inc.3,678,8648.0%EDGAR
SC 13G/A2020-01-07WELLINGTON MANAGEMENT GROUP LLPAudentes Therapeutics, Inc.622,0111.4%EDGAR
SC 13G/A2019-11-12FMR LLCAudentes Therapeutics, Inc.1,058,8162.3%EDGAR
SC 13G2019-09-16GREAT POINT PARTNERS LLCAudentes Therapeutics, Inc.2,325,0005.1%EDGAR
SC 13G/A2019-02-14PRICE T ROWE ASSOCIATES INC /MD/Audentes Therapeutics, Inc.891,1812.0%EDGAR
SC 13G/A2019-02-14Partner Fund Management, L.P.Audentes Therapeutics, Inc.-7.1%EDGAR
SC 13G2019-02-14Redmile Group, LLCAudentes Therapeutics, Inc.2,301,6675.4%EDGAR
SC 13G/A2019-02-13FMR LLCAudentes Therapeutics, Inc.3,151,8847.4%EDGAR
SC 13G/A2019-02-135AM VENTURES III, L.P.Audentes Therapeutics, Inc.1,476,4923.5%EDGAR
SC 13G/A2019-02-13ORBIMED ADVISORS LLCAudentes Therapeutics, Inc.1,893,5004.4%EDGAR
SC 13G/A2019-02-12WELLINGTON MANAGEMENT GROUP LLPAudentes Therapeutics, Inc.3,381,0707.9%EDGAR
SC 13G2019-02-08BlackRock Inc.Audentes Therapeutics, Inc.2,974,5917.0%EDGAR
SC 13G2018-10-29Partner Fund Management, L.P.Audentes Therapeutics, Inc.-6.0%EDGAR
SC 13G/A2018-10-10FMR LLCAudentes Therapeutics, Inc.3,896,39110.4%EDGAR
SC 13G/A2018-09-10FMR LLCAudentes Therapeutics, Inc.3,621,6939.7%EDGAR
External links